www.mnsclctreatmentoption-hcp.com
AdAn Approach for mNSCLC Patients Who Have Progressed On or After Platinum-Based Therapy. This Treatment Option Disrupts Cancer Cell Viability without Affecting Health Cells.
mNSCLC Treatment Option · For 2L+ mNSCLC · New Treatment Option · Official HCP Site
Types: Adverse Event Guidance, Patient Identification, Study Design & Results